Here are what the editors at HealthDay consider to be the most important developments in Pathology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Symptom Combos Suggesting Laryngeal Cancer Identified
THURSDAY, Jan. 31, 2019 (HealthDay News) — New symptom combinations that may indicate early symptoms of laryngeal cancer have been identified, according to a study published online Jan. 28 in the British Journal of General Practice.
Lean Body Mass in Childhood Linked to Lung Function at 15
FRIDAY, Jan. 25, 2019 (HealthDay News) — Higher lean body mass during childhood and adolescence is associated with higher lung function at age 15 years for both sexes, according to a study published online Jan. 11 in the American Journal of Respiratory and Critical Care Medicine.
Abstract/Full Text (subscription or payment may be required)
Psychopathology in Adulthood Up With Child Lead Exposure
THURSDAY, Jan. 24, 2019 (HealthDay News) — Higher childhood blood lead levels are associated with more psychopathology during the life course, according to a study published online Jan. 23 in JAMA Psychiatry.
Improved Genetic Risk Score Aids Type 1 Diabetes Classification
FRIDAY, Jan. 25, 2019 (HealthDay News) — An improved type 1 diabetes (T1D) genetic risk score (GRS), the T1D GRS2, is highly useful for classifying adult incident diabetes type and improving newborn screening, according to a study published in the February issue of Diabetes Care.
Abstract/Full Text (subscription or payment may be required)
Report IDs Areas Lacking Good Practice in Health Tech Assessment
FRIDAY, Jan. 25, 2019 (HealthDay News) — In a report published in the January issue of Value in Health, an ISPOR–The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).
Abstract/Full Text (subscription or payment may be required)
Plasma Marker Predicts Allograft Failure in Lung Transplant
THURSDAY, Jan. 24, 2019 (HealthDay News) — Donor-derived cell-free DNA (ddcfDNA) is a potential biomarker that can predict allograft failure after lung transplantation, according to a study published online Jan. 23 in EBioMedicine.
BP >120/80 mm Hg Linked to Lower Gray Matter Volume
THURSDAY, Jan. 24, 2019 (HealthDay News) — In young adults, lower gray matter volume (GMV) is seen in individuals with blood pressure (BP) >120/80 mm Hg, according to a study published online Jan. 23 in Neurology.
Abstract/Full Text (subscription or payment may be required)
Smoking Tied to Peripheral Artery Disease in African-Americans
Adenotonsillectomy Tied to Lower Health Care Use in Pediatric Sleep Disordered Breathing 
Length of Stay After Lung Cancer Surgery Longer With Wildfire in County of Treating Facility 
Intraoperative Remifentanil, Sufentanil Tied to Poor Postoperative Pain Experience 
No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia 
One in Five Idiopathic Pulmonary Fibrosis Deaths May Be Due to Occupational Exposures 
Complications, Mortality Up With Surgery Immediately Preceding Weekend 
Ultra-Rapid Molecular-Genetic Assays Feasible for Tumor Classification During Surgery 
Increase Seen in Percentage of Rural Patients Traveling More Than an Hour for Surgical Care 
